ADICET BIO INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To elect two class III directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027: Andrew Sinclair, Ph.D.

ADICET BIO INC.’s own tally for this item (“Elect Director: Andrew Sinclair, Ph.D.”): 38,036,535 for, 11,108,161 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 3,460,690 for, 3,537,173 withheld, 210,372 abstained.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: To elect two class III directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027: Michael G. Kauffman, M.D., Ph.D.

ADICET BIO INC.’s own tally for this item (“Elect Director: Michael G. Kauffman, M.D., Ph.D.”): 41,712,563 for, 7,432,133 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 6,081,247 for, 956,002 withheld, 170,986 abstained.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: To amend the Third Amended and Restated Certificate of Incorporation to limit the liability of certain of the Company's officers as permitted by Delaware law.

ADICET BIO INC.’s own tally for this item (“4. Approval of an Amendment to Adicet Bio, Inc. Third Amended and Restated Certificate of Incorporation to Limit the Liability of Certain of the Company's Officers as Permitted by Delaware Law”): 43,646,665 for, 5,491,648 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4- Approval of an Amendment to Adicet Bio, Inc. Third Amended and Restated Certificate of Incorporation to Limit the Liability of Certain of the Company's Officers as Permitted by Delaware Law The stockholders of the Company approved the Exculpation Amendment to limit the liability of cert…”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 7,175,217 for, 33,018 against.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: To amend the Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000.

The 38 asset managers below reported 7,094,624 for, 113,611 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Description as filed by funds: To amend the Adicet Bio, Inc. Second Amended and Restated 2018 Stock Option and Incentive Plan to increase the number of shares of common stock authorized for issuance under the plan by 5,000,000 shares of common stock.

The 39 asset managers below reported 300 for, 7,208,235 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

Description as filed by funds: To ratify, on a non-binding advisory basis, the compensation of our named executive officers.

ADICET BIO INC.’s own tally for this item (“5. Non-Binding Advisory Vote on Compensation of the Company's Named Executive Officers”): 29,915,289 for, 19,213,617 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 – Non-Binding Advisory Vote on Compensation of the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”
Support: 61% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 38 managers: 52,003 for, 7,156,232 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 78 managers: 30,088,076 for, 13,249,665 against, 27,047 1 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of our named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 38 managers: 7,152,189 1 year, 56,046 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 76 managers: 80 for, 35,072 against, 43,248,007 1 year, 55,828 3 year, 1,184 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

ADICET BIO INC.’s own tally for this item (“7. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 61,549,197 for, 8,657 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 7 – Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 7,208,235 for.

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.